EEvercore MMicrosoft · MSFT

Evercore ISI Hikes Microsoft Price Target to $525

Jul 15, 2026· 1 min read· Reproduced verbatim
Rating
Buy
Price target
$525
Previous
$510
Implied upside
+36%

Evercore ISI analyst Kirk Materne raised the price target on Microsoft (NASDAQ: MSFT) to $525 (from $510) while maintaining an Outperform rating.

“At a macro level, Microsoft’s business remains on strong footing with revenue growth and operating income expected to grow in the double digits in FY27.

However, shares remain stuck in a trading range as momentum/growth investors want to see Azure revenue accelerate and Copilot monetization/usage inflect; while value investors are looking for an ‘all clear’ sign in terms of when cash flow could bottom and comfort that incremental GM headwinds will not negatively impact EPS expectations.

Given that we expect Microsoft to remain aggressive as it relates to its AI investments, we do not see F4Q being a major inflection point as it relates to the debate on capex spend (we believe the Street remains a bit low at ~$180bn in FY27 cash capex, EVR-ISI: ~$210bn).

That said, we believe seeing Azure accelerate in 2H and further Copilot monetization could help shares to start to build some momentum as capex growth could start to normalize in 2027.

Bottom line: We believe that the risk/reward continues to skew to the upside and if MSFT can provide some additional clarity on when FCF could infect, the upside optionality is material.

In our view, sentiment is overly apathetic at current levels, and we see an attractive catalyst path for MSFT in 2H CY26 with Azure acceleration on tap, Copilot momentum starting to build, and capex growth likely to peak in the coming quarters.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.